Cargando…

The impact of COVID-19 on national targets in radical lung cancer radiotherapy: a single centre clinical audit

Detalles Bibliográficos
Autores principales:	Durno, Kimberley, Conibear, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. Published by Elsevier B.V. 2022
Materias:	COVID and Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829683/ http://dx.doi.org/10.1016/S0169-5002(22)00069-1

Ejemplares similares

No evidence of increased susceptibility to COVID-19 virus among radical lung radiotherapy patients
por: Lepiarczyk, Oskar, et al.
Publicado: (2021)

The impact of the Covid-19 pandemic on lung cancer incidence in England: an analysis of the 2019 and 2020 Rapid Cancer Registration Datasets
por: Gysling, Savannah, et al.
Publicado: (2022)

Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)
por: Banfill, Kathryn Banfill, et al.
Publicado: (2021)

Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset
por: Morgan, Helen, et al.
Publicado: (2022)

Delivering bronchoscopy and respiratory diagnostic service for lung cancer during COVID-19 pandemic: a single-centre experience
por: Yeo, Sue-Lis, et al.
Publicado: (2021)

The effect of COVID-19 on the presentation, staging, and treatment of lung cancer: a retrospective comparative audit of the ‘first wave’
por: Evetts, Lisa, et al.
Publicado: (2021)

How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
por: Kathirgamakarthigeyan, Sangary, et al.
Publicado: (2022)

The National Lung Cancer Audit: The Impact of COVID-19
por: Conibear, J., et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on lung cancer diagnosis and stage at Plymouth NHS Trust
por: McDill, Helen, et al.
Publicado: (2021)

Lung cancer diagnosis: impact of the COVID-19 pandemic
por: Ali, Sohail, et al.
Publicado: (2021)

Quantifying the impact of Covid-19 on lung cancer: an urgent need for restoration
por: O’Dowd, Emma, et al.
Publicado: (2021)

The impact of virtual lung MDT meetings (MDTMs) in response to the COVID-19 pandemic
por: Groothuizen, Hanna, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on suspected lung cancer referrals and subsequent lung cancer diagnoses at North Bristol NHS Trust (NBT)
por: Coombs, Catherine, et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on referrals and diagnoses of lung cancer in a tertiary hospital
por: Arberry, Jamie, et al.
Publicado: (2021)

Impact of COVID-19 lockdown on new lung cancer diagnosis at the Royal Gwent Hospital
por: Elahi, Aarij, et al.
Publicado: (2023)

The impact of COVID-19 on lung cancer diagnostics – a multicentre comparison of 2019/2020 data
por: Navani, Neal, et al.
Publicado: (2021)

Patient and physician opinion of virtual care in the oncology department of an Irish tertiary care centre in the era of Covid-19
por: O’Reilly, Mary, et al.
Publicado: (2021)

The effects of COVID-19 pandemic on lung cancer diagnosis
por: Sinthiya, Mariya, et al.
Publicado: (2022)

Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus
por: Derby, Sarah, et al.
Publicado: (2021)

Maintaining flexible bronchoscopy and endobronchial ultrasound (EBUS) services during the COVID-19 pandemic at a tertiary centre: the Manchester Royal Infirmary experience
por: Nasr, Eman, et al.
Publicado: (2021)

Impact of COVID-19 on mesothelioma clinical nurse specialists
por: Taylor, Bethany, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland – results from a Global Lung Cancer Coalition (GLCC) survey
por: Dallas, Lorraine, et al.
Publicado: (2021)

The continued impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland: results from the second Global Lung Cancer Coalition (GLCC) survey
por: McNamara, Aoife, et al.
Publicado: (2022)

Incidence and outcomes of central airway obstruction in new lung cancer diagnoses prior to and during COVID-19
por: Zaki, Irfan, et al.
Publicado: (2022)

Use of single-agent pembrolizumab as first-line treatment for non-small cell lung cancer with PDL1 status 50% as per NHS England interim guidance during the COVID-19 pandemic at Southend University Hospital
por: Sen, Rebecca, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on pleural activity at Plymouth NHS Trust
por: McDill, Helen, et al.
Publicado: (2021)

Lung cancer upstaging due to the COVID-19 pandemic
por: Vella, Claire, et al.
Publicado: (2021)

Covid-19 in lung cancer patients in a DGH
por: Aujayeb, Avinash
Publicado: (2021)

Adapting lung cancer diagnostics during the Covid-19 pandemic
por: Bull, Alex
Publicado: (2021)

Lung nodule management in Covid-19: does postponed surveillance matter?
por: Ratnakumar, Ratnaprashanthika, et al.
Publicado: (2021)

Emergency presentation of lung cancer: did it increase during the COVID-19?
por: Lupei, Cai, et al.
Publicado: (2021)

Anxiety and depression in lung cancer patients during Covid-19 pandemic
por: Jacob, Anitha, et al.
Publicado: (2021)

Does the use of primary care spirometry results in patients referred with suspected lung cancer have potential to avoid delays in the lung cancer referral pathway as a result of the SARS-COV-2 pandemic?
por: Ni Chleirigh, Romy, et al.
Publicado: (2021)

The effects of the COVID-19 pandemic on the lung cancer service at Northwick Park Hospital (NWPH)
por: Anandan, Lavanya, et al.
Publicado: (2021)

‘Your cough could be masking something else’ – raising awareness of lung cancer during the Covid-19 pandemic
por: Mc Namara, Aoife
Publicado: (2021)

Contact with lung cancer patients during COVID-19: findings from Ireland and the UK from a global survey of patient experience
por: McNamara, Aoife, et al.
Publicado: (2022)

Analysis of the source of lung cancer diagnoses during 2020 COVID-19 pandemic compared with 2015-2019 in the York and Scarborough NHS Trust
por: Watchorn, Hazel
Publicado: (2021)

Assessment of the impact of SARS-CoV-2 PCR results amongst thoracic oncology patients
por: Greenwood, Helene, et al.
Publicado: (2022)

The impact of SARS-COV-2 pandemic on pleural services, diagnosis of malignant effusions and junior doctors’ procedural training
por: Riddell, Nathan, et al.
Publicado: (2021)

Evaluation of telephone consultations for follow up lung cancer patients at Royal Papworth Hospital, undertaken instead of face-to-face consultations during the Covid-19 pandemic
por: Haslop, Claire, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g6nk6qpm37giul2fa6n8403m5t